FDA pushes back Ascendis' dwarfism drug decision date by three months
FDA pushes back Ascendis' dwarfism drug decision date by three months
المحتوى غير متاح. يرجى الرجوع إلى المصدر الأصلي.
FDA pushes back Ascendis' dwarfism drug decision date by three months